is hims semaglutide legit & Hers falls 8% as FDA issues warning letter over compounded weight loss drug Ticker: Hims & Hers drops

The questionnaire is structured to support standardized review and minimize incomplete submissions

In phase 3 trials, maximal dose retatrutide demonstrated 29% placebo-adjusted weight loss at 68 weeks (albeit with higher discontinuation rates than semaglutide and tirzepatide)

Neuropharmacology 185 , 108453 (2021)

Choose brand-name (Wegovy or Ozempic) if: Your insurance covers it with a manageable copay You qualify for the FDA-approved indication (BMI threshold, T2D diagnosis) You prefer the standardization of FDA-registered manufacturing You want supporting clinical evidence directly applicable to what you are taking Consider compounded semaglutide if: You are paying cash or your insurance does not cover Wegovy You do not meet the FDA-approved BMI thresholds but want to start GLP-1 therapy under medical supervision You need a customized formulation (B12 combination, dose customization, allergen-free) Your physician has worked with reputable compounding pharmacies and can verify quality How to Access Each Brand: Doctor visit (primary care, endocrinologist, or weight-management specialist) prescription pharmacy fill insurance prior authorization or cash pay

It offers the ease of daily dosing and is covered by some insurance plans